This is a regulatory disclosure filed with BSE Limited and the National Stock Exchange of India Limited. The company is intimating the cancellation of its earnings call pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The earnings call was previously scheduled for Monday, 19 October 2026, at 05:00 p.m. IST, as intimated in an earlier communication dated 13 October 2026. The call was intended to be held following the announcement of the company's financial results for the quarter and half-year ended 30 September 2026.
The company states that this earnings call has been cancelled due to unforeseen circumstances. The disclosure expresses regret for any inconvenience caused.
The information regarding this cancellation will be made available on the company's website at www.tatvachintan.com.
The document is digitally signed by Ishwar Ramanbhai Nayi, Company Secretary and Compliance Officer (Membership No.: A37444), on behalf of Tatva Chintan Pharma Chem Limited on 19 October 2026 at 16:03:53 IST.